Randomized Clinical Trial of Matching Client Alcohol Use Disorder Severity and Level of Cognitive Functioning to Treatment Setting: A Partial Replication and Extension

被引:4
|
作者
Rychtarik, Robert G. [1 ]
McGillicuddy, Neil B. [1 ]
Papandonatos, George D. [2 ]
Whitney, Robert B. [3 ]
Connors, Gerard J. [1 ]
机构
[1] Univ Buffalo State Univ New York, Res Inst Addict, 1021 Main St, Buffalo, NY 14203 USA
[2] Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA
[3] Univ Buffalo State Univ New York, Dept Family Med, Buffalo, NY 14203 USA
关键词
alcohol use disorders; treatment settings; inpatient; outpatient; expectancy; OUTPATIENT TREATMENT; INPATIENT; PSYCHOTHERAPY; EXPECTATIONS; MECHANISMS; ABUSE;
D O I
10.1037/adb0000253
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
In a tightly controlled, clinical research environment, Rychtarik et al. (2000) found that individuals with an alcohol use disorder (AUD) benefited more from inpatient (IP) than outpatient care, if they presented with high alcohol problem severity and/or low cognitive functioning. This study sought to (a) validate and extend these findings within the uncontrolled environment of a community-based treatment center and (b) test whether inpatients had fewer days of involuntary abstinence (e.g., incarcerations), controlling for differences in treatment expectancy across care settings. Clients (N = 176) with an AUD were deterministically assigned to inpatient-need group (needs IP = high severity and/or low cognitive functioning; no need for IP = neither high severity nor low cognitive functioning). Within need group, participants were randomly assigned to 21 days of routine inpatient or outpatient care, plus 6 months of continuing care. Primary outcomes of percentage of days abstinent (PDA), monthly point prevalence abstinence (PPA), and drinks per drinking day (DDD), and the secondary outcome of involuntary abstinence were assessed over 18 months. Among high-severity participants, inpatients significantly reduced DDD, and outpatients did not. Neither problem severity nor cognitive functioning moderated other setting effects. Treatment expectancy, assessed after being informed of scheduled setting, was higher among inpatients than outpatients. High-expectancy inpatients maintained the highest PDA throughout follow-up, had the highest PPA for most of follow-up, and delayed peak prevalence of involuntary abstinence by 6 months. In sum, the Alcohol Problem Severity x Setting interaction on DDD appears robust. The potential moderating role of expectancy will warrant further study.
引用
收藏
页码:513 / 523
页数:11
相关论文
共 50 条
  • [22] N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial
    Back, Sudie E.
    Gray, Kevin
    Santa Ana, Elizabeth
    Jones, Jennifer L.
    Jarnecke, Amber M.
    Joseph, Jane E.
    Prisciandaro, James
    Killeen, Therese
    Brown, Delisa G.
    Taimina, Linda
    Compean, Ebele
    Malcolm, Robert
    Flanagan, Julianne C.
    Kalivas, Peter W.
    CONTEMPORARY CLINICAL TRIALS, 2020, 91
  • [23] NETWORK SUPPORT II: RANDOMIZED CONTROLLED TRIAL OF NETWORK SUPPORT TREATMENT AND COGNITIVE BEHAVIORAL THERAPY FOR ALCOHOL USE DISORDER
    Litt, M. D.
    Kadden, R. M.
    Tennen, H.
    Kabela-Cormier, E.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 40 : 66A - 66A
  • [24] Network Support II: Randomized controlled trial of Network Support treatment and cognitive behavioral therapy for alcohol use disorder
    Litt, Mark D.
    Kadden, Ronald M.
    Tennen, Howard
    Kabela-Cormier, Elise
    DRUG AND ALCOHOL DEPENDENCE, 2016, 165 : 203 - 212
  • [25] Melatonin for Treatment-Seeking Alcohol Use Disorder patients with sleeping problems: A randomized clinical pilot trial
    Gendy, Marie N. S.
    Lagzdins, Dina
    Schaman, Jessika
    Le Foll, Bernard
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [26] Melatonin for Treatment-Seeking Alcohol Use Disorder patients with sleeping problems: A randomized clinical pilot trial
    Marie N. S. Gendy
    Dina Lagzdins
    Jessika Schaman
    Bernard Le Foll
    Scientific Reports, 10
  • [27] Sleep as an Important Target or Modifier in Alcohol Use Disorder Clinical Treatment: Example From a Recent Gabapentin Randomized Clinical Trial
    Hoffman, Michaela
    Voronin, Konstantin
    Book, Sarah W.
    Prisciandaro, James
    Bristol, Emily J.
    Anton, Raymond F.
    JOURNAL OF ADDICTION MEDICINE, 2024, 18 (05) : 520 - 525
  • [28] Cognitive-Behavior Therapy for Concurrent Anxiety and Alcohol Use Disorder: A Randomized Control Trial
    Tony Toneatto
    Kim Calderwood
    International Journal of Mental Health and Addiction, 2015, 13 : 297 - 306
  • [29] Cognitive-Behavior Therapy for Concurrent Anxiety and Alcohol Use Disorder: A Randomized Control Trial
    Toneatto, Tony
    Calderwood, Kim
    INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, 2015, 13 (02) : 297 - 306
  • [30] Ibudilast for alcohol use disorder: study protocol for a phase II randomized clinical trial
    Elizabeth M. Burnette
    Wave-Ananda Baskerville
    Erica N. Grodin
    Lara A. Ray
    Trials, 21